Guideline for the diagnosis and treatment of hypothyroidism and hypoparathyroidism in patients with blood transfusion-dependent thalassemia

Iron overload can adversely affect thyroid and parathyroid function in patients with transfusion-dependent thalassemia. iron deposition in both glands or the pituitary gland, which controls thyroid function, can lead to their destruction and dysfunction. hypothyroidism can cause symptoms such as fatigue, weight gain, and depression, while hypoparathyroidism can cause symptoms such as numbness and tingling in the hands and feet, muscle cramps, and seizures. regular thyroid and parathyroid function monitoring is essential in thalassemia patients to detect any dysfunction early and provide appropriate treatment. treatment may include medications to replace thyroid hormone or calcium and vitamin d supplements to manage hypoparathyroidism. a comprehensive approach to managing endocrine complications in thalassemia patients can improve outcomes and quality of life for these individuals. to provide professional healthcare members with clear and concise recommendations for diagnosing and treating hypothyroidism and hypoparathyroidism in transfusion dependent thalassemia patients, a practical national guideline should be developed.